Aug 07, 2019 / 02:00PM GMT
Operator
Good afternoon, ladies and gentlemen. Welcome to the Epigenomics AG conference call regarding results Q2 2019. (Operator Instructions)
Let me now turn the floor over to your host, Mr. Frederic Hilke.
Frederic Hilke - Epigenomics AG - IR Officer
Thank you very much, Saena. Hello and welcome to the conference call for the financial results of the first 6 months of 2019. My name is Frederic Hilke. I'm the Investor Relations Manager for Epigenomics. With me on the phone is the CEO of Epigenomics AG, Greg Hamilton. Before I hand over the presentation to Greg, let me point out some of the usual legal information.
The following presentation will contain expressly or implicitly certain forward-looking statements concerning Epigenomics AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Epigenomics AG to be materially different from any future results, performance or achievements expressed or implied by
Q2 2019 Epigenomics AG Earnings Call (German) Transcript
Aug 07, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers